Statistici de bază
| CIK | 1271057 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to China-biotics, Inc
SEC Filings (Chronological Order)
Această pagină oferă o listă completă, cronologică, a dosarelor SEC, cu excepția dosarelor de proprietate pe care le oferim în altă parte.
| November 4, 2013 |
begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C$W,2`P(&]B:@T\/"],:6YE87)I>F5D(#$O3"`R M,3%LQ-S$@ M,C!=+TEN9F\@,3F4@,3DQ+U1Y<&4O6%)E9B]76S$@,B`Q73X^Z@Y,>W7,]R3U#+,GN M08+"$9E6YV/G?;^=Q9GBH-#.+<>OI-[>GQ'=?ONA>D MWK4>OF-[E[<^>Z%'=6[Y-Z!!%]`&07?2V!2D:G3(E,;.!HZP$BB@:,#1#18 M=#18@-@=C!VL'1W,'1UL'4#IC(X&#Q@"JL@`DQTL'2#$!%4#!=3R)A`4,##] MF@RD68&8`RR2QB#`$,]LQ?:>2]Y$GX&A^QS3;)!P,0-SEQZ09@0%,Q"7,3#/ M?@CA, |
|
| August 14, 2013 |
10-Q 1 v35261510q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q þ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2013 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the Transition Period from to 001-34123 (Commission File Number) CHINA-BIOTICS, INC. (Exa |
|
| July 12, 2013 |
CHBT FORM 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2013 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to 333-110733 (Commission File Number) CHINA-BIOTICS, INC. (Exact na |
|
| July 1, 2013 |
UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 OMB Number: 3235-0058 Expires: June 30, 2013 Estimated average burden hours per response.......2.50 SEC FILE NUMBER NOTIFICATION OF LATE FILING 333-110733 CUSIP NUMBER (Check One): x Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D £ Form N-SAR ¨ Form N-CSR 16937B109 For Period Ended: March 31 |
|
| June 24, 2013 |
CHBT FORM 10-Q (Quarterly Report) 10-Q 1 v34812210q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q þ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2011 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the Transition Period from to 001-34123 (Commission File Number) CHINA-BIOTICS, INC. (Exa |
|
| June 24, 2013 |
CHBT FORM 10-Q (Quarterly Report) 10-Q 1 v34812510q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q þ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2011 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the Transition Period from to 001-34123 (Commission File Number) CHINA-BIOTICS, INC. |
|
| June 24, 2013 |
CHBT FORM 10-Q (Quarterly Report) 10-Q 1 v34812310q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q þ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2011 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the Transition Period from to 001-34123 (Commission File Number) CHINA-BIOTICS, INC. |
|
| May 21, 2013 |
CHBT FORM 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2011 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to 333-110733 (Commission File Number) CHINA-BIOTICS, INC. (Exact na |
|
| November 14, 2012 |
OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response 2. |
|
| August 14, 2012 |
OMB APPROVAL MB Number: 3235-0058 Expires: August 31, 2012 Estimated average burden hours per response. |
|
| June 29, 2012 |
OMB APPROVAL MB Number: 3235-0058 Expires: June 30, 2012 Estimated average burden hours per response. |
|
| February 29, 2012 |
Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 22, 2012 CHINA-BIOTICS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34123 98-0393071 (Commission F |
|
| February 29, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 25, 2012 CHINA-BIOTICS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34123 98-0393071 (Commission F |
|
| February 9, 2012 |
SEC File Number: 333-110733 CUSIP Number: 16937B109 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
